Global Preclinical Research Service Supply, Demand and Key Producers, 2023-2029
The global Preclinical Research Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Preclinical Research Service is a service provided by research organizations or laboratories that conduct extensive preclinical studies to assess the safety, efficacy, and potential toxicity of drug compounds or new medical treatments before they proceed to human clinical trials.
This report studies the global Preclinical Research Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Preclinical Research Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Preclinical Research Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Preclinical Research Service total market, 2018-2029, (USD Million)
Global Preclinical Research Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Preclinical Research Service total market, key domestic companies and share, (USD Million)
Global Preclinical Research Service revenue by player and market share 2018-2023, (USD Million)
Global Preclinical Research Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Preclinical Research Service total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Preclinical Research Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Altasciences, VIMTA, Precision Medicine, NAMSA, Charles River, Medicilon, Oncodesign Services, Veranex and Jubilant Biosys, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Preclinical Research Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Preclinical Research Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Preclinical Research Service Market, Segmentation by Type
Non GLP Safety Assessment
GLP Safety Assessment
Global Preclinical Research Service Market, Segmentation by Application
Virology
Immunology
Molecular Biology
Pathology
Others
Companies Profiled:
Altasciences
VIMTA
Precision Medicine
NAMSA
Charles River
Medicilon
Oncodesign Services
Veranex
Jubilant Biosys
IDEXX Laboratories
BioTrial
VIRTUS
Cynbiose
LifeTec
AmplifyBio
Certis
Noble Life Sciences
Veeda
QPS
Key Questions Answered
1. How big is the global Preclinical Research Service market?
2. What is the demand of the global Preclinical Research Service market?
3. What is the year over year growth of the global Preclinical Research Service market?
4. What is the total value of the global Preclinical Research Service market?
5. Who are the major players in the global Preclinical Research Service market?
- 1 Supply Summary
- 1.1 Preclinical Research Service Introduction
- 1.2 World Preclinical Research Service Market Size & Forecast (2018 & 2022 & 2029)
- 1.3 World Preclinical Research Service Total Market by Region (by Headquarter Location)
- 1.3.1 World Preclinical Research Service Market Size by Region (2018-2029), (by Headquarter Location)
- 1.3.2 United States Preclinical Research Service Market Size (2018-2029)
- 1.3.3 China Preclinical Research Service Market Size (2018-2029)
- 1.3.4 Europe Preclinical Research Service Market Size (2018-2029)
- 1.3.5 Japan Preclinical Research Service Market Size (2018-2029)
- 1.3.6 South Korea Preclinical Research Service Market Size (2018-2029)
- 1.3.7 ASEAN Preclinical Research Service Market Size (2018-2029)
- 1.3.8 India Preclinical Research Service Market Size (2018-2029)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Preclinical Research Service Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Preclinical Research Service Major Market Trends
- 2 Demand Summary
- 2.1 World Preclinical Research Service Consumption Value (2018-2029)
- 2.2 World Preclinical Research Service Consumption Value by Region
- 2.2.1 World Preclinical Research Service Consumption Value by Region (2018-2023)
- 2.2.2 World Preclinical Research Service Consumption Value Forecast by Region (2024-2029)
- 2.3 United States Preclinical Research Service Consumption Value (2018-2029)
- 2.4 China Preclinical Research Service Consumption Value (2018-2029)
- 2.5 Europe Preclinical Research Service Consumption Value (2018-2029)
- 2.6 Japan Preclinical Research Service Consumption Value (2018-2029)
- 2.7 South Korea Preclinical Research Service Consumption Value (2018-2029)
- 2.8 ASEAN Preclinical Research Service Consumption Value (2018-2029)
- 2.9 India Preclinical Research Service Consumption Value (2018-2029)
- 3 World Preclinical Research Service Companies Competitive Analysis
- 3.1 World Preclinical Research Service Revenue by Player (2018-2023)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Preclinical Research Service Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Preclinical Research Service in 2022
- 3.2.3 Global Concentration Ratios (CR8) for Preclinical Research Service in 2022
- 3.3 Preclinical Research Service Company Evaluation Quadrant
- 3.4 Preclinical Research Service Market: Overall Company Footprint Analysis
- 3.4.1 Preclinical Research Service Market: Region Footprint
- 3.4.2 Preclinical Research Service Market: Company Product Type Footprint
- 3.4.3 Preclinical Research Service Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers, Acquisitions Activity
- 4 United States VS China VS Rest of the World (by Headquarter Location)
- 4.1 United States VS China: Preclinical Research Service Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Preclinical Research Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
- 4.1.2 United States VS China: Preclinical Research Service Revenue Market Share Comparison (2018 & 2022 & 2029)
- 4.2 United States Based Companies VS China Based Companies: Preclinical Research Service Consumption Value Comparison
- 4.2.1 United States VS China: Preclinical Research Service Consumption Value Comparison (2018 & 2022 & 2029)
- 4.2.2 United States VS China: Preclinical Research Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
- 4.3 United States Based Preclinical Research Service Companies and Market Share, 2018-2023
- 4.3.1 United States Based Preclinical Research Service Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Preclinical Research Service Revenue, (2018-2023)
- 4.4 China Based Companies Preclinical Research Service Revenue and Market Share, 2018-2023
- 4.4.1 China Based Preclinical Research Service Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Preclinical Research Service Revenue, (2018-2023)
- 4.5 Rest of World Based Preclinical Research Service Companies and Market Share, 2018-2023
- 4.5.1 Rest of World Based Preclinical Research Service Companies, Headquarters (States, Country)
- 4.5.2 Rest of World Based Companies Preclinical Research Service Revenue, (2018-2023)
- 5 Market Analysis by Type
- 5.1 World Preclinical Research Service Market Size Overview by Type: 2018 VS 2022 VS 2029
- 5.2 Segment Introduction by Type
- 5.2.1 Non GLP Safety Assessment
- 5.2.2 GLP Safety Assessment
- 5.3 Market Segment by Type
- 5.3.1 World Preclinical Research Service Market Size by Type (2018-2023)
- 5.3.2 World Preclinical Research Service Market Size by Type (2024-2029)
- 5.3.3 World Preclinical Research Service Market Size Market Share by Type (2018-2029)
- 6 Market Analysis by Application
- 6.1 World Preclinical Research Service Market Size Overview by Application: 2018 VS 2022 VS 2029
- 6.2 Segment Introduction by Application
- 6.2.1 Virology
- 6.2.2 Immunology
- 6.2.3 Molecular Biology
- 6.2.4 Pathology
- 6.2.5 Pathology
- 6.3 Market Segment by Application
- 6.3.1 World Preclinical Research Service Market Size by Application (2018-2023)
- 6.3.2 World Preclinical Research Service Market Size by Application (2024-2029)
- 6.3.3 World Preclinical Research Service Market Size by Application (2018-2029)
- 7 Company Profiles
- 7.1 Altasciences
- 7.1.1 Altasciences Details
- 7.1.2 Altasciences Major Business
- 7.1.3 Altasciences Preclinical Research Service Product and Services
- 7.1.4 Altasciences Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.1.5 Altasciences Recent Developments/Updates
- 7.1.6 Altasciences Competitive Strengths & Weaknesses
- 7.2 VIMTA
- 7.2.1 VIMTA Details
- 7.2.2 VIMTA Major Business
- 7.2.3 VIMTA Preclinical Research Service Product and Services
- 7.2.4 VIMTA Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.2.5 VIMTA Recent Developments/Updates
- 7.2.6 VIMTA Competitive Strengths & Weaknesses
- 7.3 Precision Medicine
- 7.3.1 Precision Medicine Details
- 7.3.2 Precision Medicine Major Business
- 7.3.3 Precision Medicine Preclinical Research Service Product and Services
- 7.3.4 Precision Medicine Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.3.5 Precision Medicine Recent Developments/Updates
- 7.3.6 Precision Medicine Competitive Strengths & Weaknesses
- 7.4 NAMSA
- 7.4.1 NAMSA Details
- 7.4.2 NAMSA Major Business
- 7.4.3 NAMSA Preclinical Research Service Product and Services
- 7.4.4 NAMSA Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.4.5 NAMSA Recent Developments/Updates
- 7.4.6 NAMSA Competitive Strengths & Weaknesses
- 7.5 Charles River
- 7.5.1 Charles River Details
- 7.5.2 Charles River Major Business
- 7.5.3 Charles River Preclinical Research Service Product and Services
- 7.5.4 Charles River Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.5.5 Charles River Recent Developments/Updates
- 7.5.6 Charles River Competitive Strengths & Weaknesses
- 7.6 Medicilon
- 7.6.1 Medicilon Details
- 7.6.2 Medicilon Major Business
- 7.6.3 Medicilon Preclinical Research Service Product and Services
- 7.6.4 Medicilon Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.6.5 Medicilon Recent Developments/Updates
- 7.6.6 Medicilon Competitive Strengths & Weaknesses
- 7.7 Oncodesign Services
- 7.7.1 Oncodesign Services Details
- 7.7.2 Oncodesign Services Major Business
- 7.7.3 Oncodesign Services Preclinical Research Service Product and Services
- 7.7.4 Oncodesign Services Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.7.5 Oncodesign Services Recent Developments/Updates
- 7.7.6 Oncodesign Services Competitive Strengths & Weaknesses
- 7.8 Veranex
- 7.8.1 Veranex Details
- 7.8.2 Veranex Major Business
- 7.8.3 Veranex Preclinical Research Service Product and Services
- 7.8.4 Veranex Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.8.5 Veranex Recent Developments/Updates
- 7.8.6 Veranex Competitive Strengths & Weaknesses
- 7.9 Jubilant Biosys
- 7.9.1 Jubilant Biosys Details
- 7.9.2 Jubilant Biosys Major Business
- 7.9.3 Jubilant Biosys Preclinical Research Service Product and Services
- 7.9.4 Jubilant Biosys Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.9.5 Jubilant Biosys Recent Developments/Updates
- 7.9.6 Jubilant Biosys Competitive Strengths & Weaknesses
- 7.10 IDEXX Laboratories
- 7.10.1 IDEXX Laboratories Details
- 7.10.2 IDEXX Laboratories Major Business
- 7.10.3 IDEXX Laboratories Preclinical Research Service Product and Services
- 7.10.4 IDEXX Laboratories Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.10.5 IDEXX Laboratories Recent Developments/Updates
- 7.10.6 IDEXX Laboratories Competitive Strengths & Weaknesses
- 7.11 BioTrial
- 7.11.1 BioTrial Details
- 7.11.2 BioTrial Major Business
- 7.11.3 BioTrial Preclinical Research Service Product and Services
- 7.11.4 BioTrial Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.11.5 BioTrial Recent Developments/Updates
- 7.11.6 BioTrial Competitive Strengths & Weaknesses
- 7.12 VIRTUS
- 7.12.1 VIRTUS Details
- 7.12.2 VIRTUS Major Business
- 7.12.3 VIRTUS Preclinical Research Service Product and Services
- 7.12.4 VIRTUS Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.12.5 VIRTUS Recent Developments/Updates
- 7.12.6 VIRTUS Competitive Strengths & Weaknesses
- 7.13 Cynbiose
- 7.13.1 Cynbiose Details
- 7.13.2 Cynbiose Major Business
- 7.13.3 Cynbiose Preclinical Research Service Product and Services
- 7.13.4 Cynbiose Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.13.5 Cynbiose Recent Developments/Updates
- 7.13.6 Cynbiose Competitive Strengths & Weaknesses
- 7.14 LifeTec
- 7.14.1 LifeTec Details
- 7.14.2 LifeTec Major Business
- 7.14.3 LifeTec Preclinical Research Service Product and Services
- 7.14.4 LifeTec Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.14.5 LifeTec Recent Developments/Updates
- 7.14.6 LifeTec Competitive Strengths & Weaknesses
- 7.15 AmplifyBio
- 7.15.1 AmplifyBio Details
- 7.15.2 AmplifyBio Major Business
- 7.15.3 AmplifyBio Preclinical Research Service Product and Services
- 7.15.4 AmplifyBio Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.15.5 AmplifyBio Recent Developments/Updates
- 7.15.6 AmplifyBio Competitive Strengths & Weaknesses
- 7.16 Certis
- 7.16.1 Certis Details
- 7.16.2 Certis Major Business
- 7.16.3 Certis Preclinical Research Service Product and Services
- 7.16.4 Certis Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.16.5 Certis Recent Developments/Updates
- 7.16.6 Certis Competitive Strengths & Weaknesses
- 7.17 Noble Life Sciences
- 7.17.1 Noble Life Sciences Details
- 7.17.2 Noble Life Sciences Major Business
- 7.17.3 Noble Life Sciences Preclinical Research Service Product and Services
- 7.17.4 Noble Life Sciences Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.17.5 Noble Life Sciences Recent Developments/Updates
- 7.17.6 Noble Life Sciences Competitive Strengths & Weaknesses
- 7.18 Veeda
- 7.18.1 Veeda Details
- 7.18.2 Veeda Major Business
- 7.18.3 Veeda Preclinical Research Service Product and Services
- 7.18.4 Veeda Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.18.5 Veeda Recent Developments/Updates
- 7.18.6 Veeda Competitive Strengths & Weaknesses
- 7.19 QPS
- 7.19.1 QPS Details
- 7.19.2 QPS Major Business
- 7.19.3 QPS Preclinical Research Service Product and Services
- 7.19.4 QPS Preclinical Research Service Revenue, Gross Margin and Market Share (2018-2023)
- 7.19.5 QPS Recent Developments/Updates
- 7.19.6 QPS Competitive Strengths & Weaknesses
- 8 Industry Chain Analysis
- 8.1 Preclinical Research Service Industry Chain
- 8.2 Preclinical Research Service Upstream Analysis
- 8.3 Preclinical Research Service Midstream Analysis
- 8.4 Preclinical Research Service Downstream Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
- 10.3 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook